Atlas Trials

Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19

Clinical trial NCT05083039 · COMPLETED

Trial details

NCT number
NCT05083039
Sponsor
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products
Status
COMPLETED
Study type
OBSERVATIONAL
Coronavirus InfectionsVaccinePolio
Start date
2020-05-14
Primary completion
2020-12-14
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.